ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonstrating Avacopan’s Superiority Over Standard of Care in ANCA-Associated Vasculitis

    NEXT STORY
    Chembio Diagnostics Completes Acquisition of Orangelife
    PREV STORY
    FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Notification from Oasmia Pharmaceutical AB

    Oasmia Pharmaceutical AB hereby issues a notification that the Company has submitted a Form ...

    author_avatar
    NASDAQ Market News

    Cyclacel Pharmaceuticals to Present at the Noble Capital Markets Investor Conference

    BERKELEY HEIGHTS, N.J., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ...

    author_avatar
    NASDAQ Market News

    Houston Dermatologist Reveals Laser Treatment Options for Birthmarks

    HOUSTON, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Most birthmarks, including Becker’s Nevus and Nevus ...

    author_avatar
    NASDAQ Market News